Cross-Sector entity
Accel is the most frequent co-covered peer, appearing in 3 of the 4 tracked stories. That works out to roughly 0.3 stories per week across a 107-day span. The busiest single day carried 3. The clearest coverage concentration is defense-tech: 1 of 4 stories, with the rest divided among 3 other categories.
4 verified stories tracked
Last mentioned: Jun 18, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 75 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Accel is the most frequent co-covered peer, appearing in 3 of the 4 tracked stories. That works out to roughly 0.3 stories per week across a 107-day span. The busiest single day carried 3. The clearest coverage concentration is defense-tech: 1 of 4 stories, with the rest divided among 3 other categories. We currently track 4 Cross-Sector stories that mention In-Q-Tel, published between March 4, 2026 and June 18, 2026. The tracked stories average 2.5 original sources each.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering In-Q-Tel. Shared-story counts are live from our verified record — not editorial picks.
Twenty becomes the first venture-backed offensive cyber warfare unicorn after a $100 million Series B led by Accel, raising $138 million total since 2024 and validating a new startup category built on government offense contracts.
The $1 billion valuation of offensive cyber startup Twenty signals a paradigm shift in defense tech procurement, with AI-driven attack capabilities becoming a critical asset for protecting space and other military domains.
Cybersecurity professionals must now reckon with the commercial industrialization of offensive AI cyber weapons, as Twenty achieves a $1 billion valuation with fresh funding to expand its attack capabilities for government clients.
Source: Cristian Dina · CNA
Colossal Biosciences is advancing its mission to revive the woolly mammoth by 2028, sparking intense debate over the ethics of de-extinction. While the startup has secured over $225 million in venture capital, critics argue the project is a costly distraction from urgent conservation efforts for living species.
